Improving therapy for patients with epidermal growth factor receptor-mutant lung cancer

Cancer. 2018 Jun 1;124(11):2272-2275. doi: 10.1002/cncr.31289. Epub 2018 Apr 12.

Authors

Kathryn C Arbour¹, Gregory J Riely¹

Affiliation

¹ Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York.

PMID: 29645085
DOI: 10.1002/cncr.31289

No abstract available

Publication types

Editorial
Comment

MeSH terms

Carcinoma, Non-Small-Cell Lung*
ErbB Receptors
Erlotinib Hydrochloride
Humans
Indazoles
Lung Neoplasms*
Proteomics
Pyrimidines
Sulfonamides

Substances

Indazoles
Pyrimidines
Sulfonamides
pazopanib
Erlotinib Hydrochloride
ErbB Receptors